Video | 30 November 2018 Explainer: Kala azar-HIV co-infection in Bihar, India TROPICAL & NEGLECTED DISEASES India Read, watch, share Filter by - Any -BlogEventsFeature storyInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechStatementTechnical briefVideo Technical brief | 04 September 2024 HIV/AIDS Hidden Costs: GeneXpert Tests and Danaher’s Delayed Audit Research article | 16 August 2024 HIV/AIDS Lancet HIV: The long wait for long-acting HIV prevention and treatment formulations Research article | 14 August 2024 HIV/AIDS Lancet Global Health: Paving the way for affordable and equitable liposomal amphotericin B access worldwide Newsletter Newsletter | 02 August 2024 HIV/AIDS Why we went to the International AIDS Conference this year...and what we did! Photograph by Jan-Joseph Stok Press release Press release | 26 July 2024 HIV/AIDS Pharmaceutical corporation ViiV must urgently supply HIV drug CAB-LA according to global public health needs 5 min Photo credit: MSF Press release Press release | 23 July 2024 HIV/AIDS Activists at AIDS2024 Demand: Break Gilead’s Lenacapavir Monopoly Gilead’s Price 100,000% Higher than Target Generic Price for 100% Effective Prevention Shot 3 min Technical brief | 05 June 2024 HIV/AIDS Antiretroviral Prices in 2023 Letter | 22 April 2024 Diagnostics Hepatitis C HIV/AIDS Ghana Ghana: National AIDS Control Programme letter to Danaher to reduce the price of GeneXpert test Load More
Technical brief | 04 September 2024 HIV/AIDS Hidden Costs: GeneXpert Tests and Danaher’s Delayed Audit
Research article | 16 August 2024 HIV/AIDS Lancet HIV: The long wait for long-acting HIV prevention and treatment formulations
Research article | 14 August 2024 HIV/AIDS Lancet Global Health: Paving the way for affordable and equitable liposomal amphotericin B access worldwide
Newsletter Newsletter | 02 August 2024 HIV/AIDS Why we went to the International AIDS Conference this year...and what we did!
Photograph by Jan-Joseph Stok Press release Press release | 26 July 2024 HIV/AIDS Pharmaceutical corporation ViiV must urgently supply HIV drug CAB-LA according to global public health needs 5 min
Photo credit: MSF Press release Press release | 23 July 2024 HIV/AIDS Activists at AIDS2024 Demand: Break Gilead’s Lenacapavir Monopoly Gilead’s Price 100,000% Higher than Target Generic Price for 100% Effective Prevention Shot 3 min
Letter | 22 April 2024 Diagnostics Hepatitis C HIV/AIDS Ghana Ghana: National AIDS Control Programme letter to Danaher to reduce the price of GeneXpert test